Isaac Barchas

The Austin Chamber of Commerce is an organization that helps people in the region achieve greater prosperity by working with businesses looking to create or expand their presence in the Austin region and help them create more jobs. The non-profit company is based in Austin, TX. The company has helped bring more than 400,000 jobs to the region since 2004 and take on the biggest challenges so businesses can focus on growing. Laura Huffman has been the CEO of the company since 2020.

Austin Technology Incubator is a deep tech incubator affiliated with the University of Texas at Austin. The non-profit company is based in Austin, TX. The company's mission is to empower university and community entrepreneurs through a customized approach to effectively commercialize their breakthrough innovations and compete in the marketplace. The company is committed to supporting deep tech solutions that will become the future for today's challenges. It was founded in 1989 and is the longest active technology incubator in Austin. The company was founded by Tab Ebrahim, Robert Norman Neville, Bart Bohn.

Pecan Street, Inc. is a non-profit company that conducts research on water and energy. The company is based in Austin, TX.

Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas.

Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.

Sustainable Opportunities Acquisition Corp. is a blank check company with no operating history and no revenues. The company was founded in 2019 is headquartered in Dallas, TX.

Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low.

MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.